Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

AIPT - Precision Therapeutics Inc.

Previous close
0.64
0.640   100.000%

Share volume: 0
Last Updated: Thu 13 Jun 2019 10:00:00 PM CEST
Medical Specialties: 0%

PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
24%
Profitability 25%
Dept financing 22%
Liquidity 59%
Performance 15%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$0.64
P/E Ratio 
N/A
DAY RANGE
$0.64 - $0.64
EPS 
-$0.84
52 WEEK RANGE
$0.40 - $1.58
52 WEEK CHANGE
-$43.86
MARKET CAP 
19.636 M
YIELD 
N/A
SHARES OUTSTANDING 
30.681 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$27,834,902
AVERAGE 10 VOLUME 
$51,614
AVERAGE 30 VOLUME 
$78,789
Company detail
CEO: Carl Schwartz
Region: US
Website: http://www.precisiontherapeutics.com
Employees: 24
IPO year: -
Issue type: Common Stock
Market: NASDAQ
Industry: Medical Specialties
Sector: Health Technology

Precision Therapeutics, Inc. engages in the manufacture and distribution of healthcare products, and provision of related services. The company offers STREAMWAY System, which is an automated system for the collection and disposal of infectious fluids from surgical and other medical procedures. It operates through the Medical Device and Consumable Products segments. The company was founded by Lawrence W. Gadbaw, Peter L. Morawetz, and Jeffrey K. Drogue on April 23, 2002 and is headquartered in Eagan, MN.

Recent news